to develop an anti-SARS-CoV-2 mAb product for prevention of severe COVID-19 in vulnerable populations in low and middle income countries
- Funded by Gates Foundation
- Total publications:7 publications
Grant number: INV-024617
Grant search
Key facts
Disease
COVID-19start year
2020Known Financial Commitments (USD)
$223,307Funder
Gates FoundationPrincipal Investigator
N/A
Research Location
NetherlandsLead Research Institution
Academisch Medisch CentrumResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Vulnerable populations unspecified
Occupations of Interest
Unspecified
Abstract
N/A
Publicationslinked via Europe PMC
Last Updated:42 minutes ago
View all publications at Europe PMC